পদ্ধতির তুলনা করুন

	কোষ্ঠকাঠিন্যের জীবনযাত্রার মান রোগীর মূল্যায়ন	ইরিটেবল বাওয়েল সিনড্রোমের জন্য রোম IV ডায়াগনস্টিক ক্রাইটেরিয়া	সংক্ষিপ্ত ইনফ্ল্যামেটরি বাওয়েল ডিজিজ প্রশ্নাবলী
ক্ষেত্র	পরিপাকতন্ত্র বিজ্ঞান	পরিপাকতন্ত্র বিজ্ঞান	পরিপাকতন্ত্র বিজ্ঞান
পরিবার	Process / pipeline	Process / pipeline	Process / pipeline
উদ্ভবের বছর	2005	2016	2004
প্রবর্তক	Marquis, P., De La Loge, C., Dubois, D., et al.	Rome Foundation (multinational expert consensus)	Guyonnet, D., Chassany, O., Ducroc, R., et al.
ধরন	Self-report	Diagnostic Criteria	Self-report
মৌলিক উৎস	Marquis, P., De La Loge, C., Dubois, D., McDermott, A., & Chassany, O. (2005). Development and validation of the Patient Assessment of Constipation-Quality of Life questionnaire. Scandinavian Journal of Gastroenterology, 40(5), 540–551.	Mearin, F., Lacy, B. E., Chang, L., et al. (2016). Bowel disorders. Gastroenterology. Published online June 2016 by the Rome Foundation.	Guyonnet, D., Chassany, O., Ducroc, R., Picard, C., Mouret, M., D'Haens, G., & Svartz, H. (2004). Effect of fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in France: A multicentre, randomized, double-blind, controlled trial. Alimentary Pharmacology & Therapeutics, 20(4), 459–465.
অপর নাম	PAC-QoL, PAC-Q	Rome IV IBS, Rome Criteria	IBDQ-32, Short IBDQ
সম্পর্কিত	4	4	4
সারসংক্ষেপ	The Patient Assessment of Constipation Quality of Life (PAC-QoL) is a validated, patient-reported outcome measure designed to assess the impact of functional constipation on physical, psychological, and social well-being. Developed by Marquis and colleagues in 2005, the PAC-QoL comprises 28 items organized into four domains: Physical Discomfort, Psychosocial Discomfort, Worries and Concerns, and Satisfaction. The PAC-QoL is responsive to treatment and widely used in constipation clinical trials and practice.	The Rome IV criteria are the internationally accepted diagnostic standard for irritable bowel syndrome (IBS), published in 2016 by the Rome Foundation. These criteria define IBS as recurrent abdominal pain (≥1 day per week for ≥3 months) associated with altered bowel habits, without structural or biochemical abnormalities. IBS is subtyped into four patterns—IBS-constipation predominant (IBS-C), IBS-diarrhea predominant (IBS-D), IBS-mixed (IBS-M), and IBS-unclassified (IBS-U)—based on stool consistency patterns.	The Short Inflammatory Bowel Disease Questionnaire (IBDQ-32) is a validated patient-reported outcome measure designed to assess the impact of inflammatory bowel disease (IBD)—both ulcerative colitis and Crohn's disease—on health-related quality of life. Derived from the original 32-item IBDQ, this instrument comprises four domains: Bowel Symptoms, Systemic Symptoms, Social Function, and Emotional Function. The IBDQ-32 is responsive to treatment and is increasingly used in IBD clinical trials and practice.